H.C. Wainwright initiates Strive Enterprises stock with buy rating By Investing.com

H.C. Wainwright initiated Strive Enterprises (NASDAQ:ASST) at Buy with a $36 price target, implying substantial upside from the current $15.62 share price. The company holds 13,768 Bitcoin worth over $1 billion, making it the ninth-largest public Bitcoin holder and the fifth-largest Bitcoin treasury company. Strive has also used proceeds from a $225 million preferred offering to retire $110 million of debt and is expanding its digital asset strategy, though InvestingPro notes the stock may be overvalued.

Analysis

ASST is increasingly behaving less like an operating company and more like a leveraged bitcoin capital-structure vehicle, which means the real earnings driver is not product revenue but the spread between implied equity value and net asset value of the treasury stack. That can work powerfully in risk-on tapes because the stock becomes a convex proxy for BTC with a narrative premium, but it also means the equity can de-rate faster than spot BTC if financing markets tighten or the premium-to-NAV compresses. The key second-order effect is that each successful capital raise lowers near-term dilution anxiety and expands the playbook for follow-on balance sheet arbitrage.

The strategic consequence for competitors is that treasury-company scale is becoming a winner-take-more game: larger names can access cheaper capital, issue preferreds, and recycle financing into BTC accumulation, while smaller entrants face a rising cost of capital and less liquidity in their equity currency. That creates a likely consolidation pressure across the Bitcoin treasury cohort, with weaker balance sheets becoming acquisition targets or forced sellers during drawdowns. SMLR is not directly exposed by this print, but any M&A activity around BTC treasury companies should increase scrutiny on financing structures and could compress multiples for peers that lack either scale or a credible capital-markets engine.

The near-term catalyst path is binary over the next 1-3 months: if BTC holds up and ASST can keep monetizing its balance sheet without widening its preferred/debt spreads, the stock can continue to re-rate on scarcity value. The main tail risk is a BTC pullback combined with a post-rally reset in the treasury trade, which would hit these names twice through mark-to-market and sentiment. The market is probably underestimating how quickly the stock can go from 'strategic compounder' to 'financing story' once the premium to underlying assets narrows.

The contrarian view is that the bullish case may already be partly priced in because investors are paying not just for BTC ownership but for optionality on future financial engineering, which can be fragile. If the market starts valuing these vehicles on a transparent NAV basis rather than narrative scarcity, upside becomes much more limited from here despite strong headline positioning. In that scenario, the best risk-adjusted trade may be to own the leaders only when they trade at a modest discount to peer-implied NAV, not during momentum spikes.

Key Decisions for Investors

• Long ASST only on pullbacks; use a 4-8 week horizon and prefer entries after a 10-15% retracement, with a trim target near prior momentum highs if the stock re-establishes a persistent premium to peer-implied NAV.
• Pair trade: long ASST / short a weaker Bitcoin treasury peer basket over 1-3 months, targeting relative outperformance from scale and financing access; cover the short if BTC volatility spikes or funding spreads widen.
• Buy ASST call spreads instead of common for a 1-2 month catalyst window; cap downside while retaining convexity to any further treasury-premium expansion, especially if BTC breaks higher.
• Avoid chasing after strong weekly moves; if BTC weakens 5-10%, expect ASST to underperform BTC on a beta-plus basis, making it vulnerable to a faster de-rating than spot.
• For fundamental long-only accounts, treat ASST as a trading vehicle rather than a core compounder until the market proves it can sustain capital raises without increasing dilution or preferred burden.